Autopsy report · NCT05205265

Rivet PVS Therapy in Group 2 PH-HFpEF

“Commercial decision”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

NXT Biomedical

Sponsor type

Industry

Conditions

Heart Failure; Pulmonary Hypertension

Interventions

Rivet Shunt

Participants

0

Sites

3

Countries

United States

Trials that died the same way

• Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)
  “Business decision.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.